No-wash kit to quantify released Human CCL4 (MIP1 beta)
Alpha-Synuclein aggregation Kit
- Low sample consumption
- High sensitivity
Monitoring alpha-synuclein aggregation is of great interest for studying the pathogenesis of synucleinopathies, a group of neurodegenerative diseases that includes Parkinson's disease (PD), dementia with Lewy bodies (DLB), diffuse Lewy body disease (DLBD), and multiple system atrophy (MSA). The kit provides a solution to rapidly detect and quantify protein aggregates of human alpha-synuclein in cell culture or brain tissue extracts.
Samples from human putamen (Parkinson's versus control) were collected and lysed with a Cisbio lysis buffer. Due to the nature of the samples, the conventional cellular protocol needed to be adjusted. Incubation was performed for 20 hours at RT. Even at high dilution (1/64), clear discrimination between the two sample types is possible with Cisbio's aggregated alpha synuclein assay.
MAP-tau quantification in cell lysates
All-in-one kit for robust detection of Total NDRG1
Human TREM-2 quantification from cells
Assay kit for the detection of Phospho-LRRK2 (Ser935)
All-in-one kit for robust detection of Total LRRK2
Tau aggregation detection in cell and brain extracts